-
1 Comment
R1 RCM Inc is currently in a long term downtrend where the price is trading 5.0% below its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.4.
R1 RCM Inc's total revenue rose by 4.6% to $328M since the same quarter in the previous year.
Its net income has increased by 907.7% to $79M since the same quarter in the previous year.
Finally, its free cash flow fell by 91.8% to $4M since the same quarter in the previous year.
Based on the above factors, R1 RCM Inc gets an overall score of 3/5.
Sector | Healthcare |
---|---|
Industry | Health Information Services |
Exchange | NASDAQ |
CurrencyCode | USD |
ISIN | US7493971052 |
Beta | None |
---|---|
PE Ratio | None |
Market Cap | 6B |
Target Price | 15.475 |
R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. R1 RCM Inc. was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. The company was incorporated in 2003 and is headquartered in Murray, Utah. As of November 19, 2024, R1 RCM Inc. was taken private.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for RCM using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025